Active Shortage

ILEVRO

NOVARTIS PHARMACEUTICALS CANADA INC

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is there a shortage of ILEVRO in Canada?

Yes. ILEVRO 0.3% has an active shortage reported to Health Canada (last updated November 4, 2026).

Why is ILEVRO not available?

The reason the manufacturer reported: Shortage of an active ingredient.

When will ILEVRO be available again?

The manufacturer's estimated resolution date is November 15, 2026. This is an estimate and can change; follow this page to get an email when the status changes.

Can I still get this?Possibly — same-ingredient product records found

StatusActive Shortage

Same-ingredient products on file1 product

Expected resolution~3 days remaining (estimate)

Affected strength0.3%

Report last updated2026-11-04

Checked by MedShort2026-11-12

Other Products Containing the Same Active Ingredient

These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.

Other Products

NEVANAC

NOVARTIS PHARMACEUTICALS CANADA INC

0.1% · DIN 02308983

Different strengthSame dosage formSame routeNo current shortage

Compare these two →

What this means

Does this mean my pharmacy is out of stock?

Not necessarily — a national shortage doesn't mean every pharmacy has run out. Some locations may still have stock, especially of a specific strength or pack size.

What should I do?

Contact your pharmacy before your current supply runs low, and ask your pharmacist about next steps if they're out.

Estimated Resolution

2026-11-15

~3 days remaining (estimate)

This is the manufacturer's estimated date, not a guarantee — actual resolution may come earlier or later.

Have you checked a pharmacy recently?

No community reports yet — be the first to share what you found.

Community reports are not verified by a pharmacy and may reflect a small sample size. This is not a guarantee of current stock.

DIN

02411393

Strength

0.3%

Dosage Form

SUSPENSION

Route

OPHTHALMIC

Active Ingredient

NEPAFENAC

Tier

Unrated

Last Updated

2026-11-04

Reason for Shortage

Shortage of an active ingredient.

Source

View original report on healthproductshortages.ca ↗

Other Products from NOVARTIS PHARMACEUTICALS CANADA INC

Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.

10MG · DIN 02339528

2.5MG · DIN 02369257

5MG · DIN 02339501

7.5MG · DIN 02450267

2MG · DIN 02425645

3MG · DIN 02425653